The treatment landscape for various types of cancer has been revolutionized over the past decade, owing significantly to the development and application of immune checkpoint inhibitors (ICIs). As a part of this paradigm shift, the CheckMate trials have played a pivotal role in evaluating the safety and efficacy of ICIs in treating different types of […]